EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Auto-Abs against type I IFNs: Strong, common, and global determinants of severe arboviral diseases

Adrian Gervais iD, Alessandro Borghesi iD, Jean-Laurent Casanova iD, Shen-Ying Zhang iD

Journal of Human Immunity · 05.01.2026 · 2 (1)

DOI: 10.70962/jhi.20250090 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Human Immunity, online erschienen am 23.10.2025. Verfasst von Adrian Gervais und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker …. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCATS NIH HHS, Howard Hughes Medical Institute.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human-tropic pathogenic arboviruses are spreading worldwide. There is immense interindividual clinical variability following infection with any arbovirus. Autoantibodies (auto-Abs) neutralizing antiviral type I IFNs (AAN-I-IFN) can underlie a small but growing number of severe arboviral diseases, whether transmitted by ticks (tick-borne encephalitis virus, TBEV; Powassan virus, POWV) or mosquitoes (West Nile virus, WNV; Usutu virus, USUV; Ross River virus, RRV) and whether due to flaviviruses (WNV, TBEV, POWV, and USUV) or alphaviruses (RRV). Evidence is documented in large cohort studies for WNV and TBEV. They can also account severe adverse reactions to the live-attenuated yellow fever virus vaccine. AAN-I-IFN are present before arboviral infection and are the cause of severe disease. Carriers of these auto-Abs are common worldwide (>100 million people), have a very high risk of severe disease (relative risk >100), and account for a sizeable proportion of cases (typically >10%). Other severe diseases due to different arboviruses may also be caused by these auto-Abs.

Autor:innen und Institutionen

  • Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale (INSERM) U1163, Necker Hospital for Sick Children, Paris, France.
  • Paris Cité University, Imagine Institute, Paris, France.
  • Host-Pathogen Group, San Matteo Research Hospital, Pavia, Italy.
  • Neonatal Intensive Care Unit, San Matteo Research Hospital, Pavia, Italy.
  • Mother, Child and Adolescent Department, Neonatal Intensive Care Unit, Geneva University Hospitals, Geneva, Switzerland.
  • Department of Pediatrics, Gynecology and Obstetrics, Faculty of Medicine, University of Geneva, Geneva, Switzerland.

ORCID-Profile: Adrian Gervais, Alessandro Borghesi, Jean-Laurent Casanova, Shen-Ying Zhang

Förderung

  • NIAID NIH HHS
  • NCATS NIH HHS
  • Howard Hughes Medical Institute
  • Rockefeller University
  • St. Giles Foundation
  • Stavros Niarchos Foundation
  • National Institutes of Health
  • National Center for Advancing Translational Sciences

Zitieren

APA

Gervais, A., Borghesi, A., Casanova, J. L., & Zhang, S. Y. (2026). Auto-Abs against type I IFNs: Strong, common, and global determinants of severe arboviral diseases. Journal of Human Immunity, 2(1). https://doi.org/10.70962/jhi.20250090

Vancouver

Gervais A, Borghesi A, Casanova JL, Zhang SY. Auto-Abs against type I IFNs: Strong, common, and global determinants of severe arboviral diseases. Journal of Human Immunity. 2026;2(1). doi:10.70962/jhi.20250090

BibTeX
@article{Gervais2026,
  author = {Gervais, Adrian and Borghesi, Alessandro and Casanova, Jean-Laurent and Zhang, Shen-Ying},
  title = {Auto-Abs against type I IFNs: Strong, common, and global determinants of severe arboviral diseases},
  journal = {Journal of Human Immunity},
  year = {2026},
  volume = {2},
  number = {1},
  doi = {10.70962/jhi.20250090}
}
Kostenlos starten →